Difficulty: Medium
Average Score: 77%
Practice
Which of the following medications is given concurrently with coronary angioplasty or intervention?
Correct answer
A
Rationale
The correct answer is A) Bivalirudin; Aspirin.
Bivalirudin is a direct thrombin inhibitor used during coronary angioplasty or intervention to prevent blood clot formation. Aspirin is a common antiplatelet medication that is given to prevent platelet aggregation and reduce the risk of clot formation. When used together, bivalirudin and aspirin provide a dual mechanism of action to prevent clot formation and maintain blood flow during the procedure.
Option B) Fondaparinux; Heparin is incorrect because fondaparinux is a factor Xa inhibitor, while heparin is a different type of anticoagulant. These medications are not typically used together during coronary angioplasty.
Option C) Enoxaparin; Coumarins is incorrect because enoxaparin is a low molecular weight heparin and coumarins are vitamin K antagonists. These medications are not commonly used together during coronary interventions.
Option D) Vitamin K inhibitors; Xa is incorrect because vitamin K inhibitors and Xa inhibitors do not directly address the immediate need for anticoagulation during coronary angioplasty. These medications are used for different indications and are not typically given concurrently during this procedure.
In an educational context, it is important for healthcare professionals to understand the rationale behind the selection of medications for specific procedures like coronary angioplasty. Knowing which medications work synergistically to prevent complications and understanding the mechanisms of action of different anticoagulants and antiplatelet agents is crucial for providing safe and effective patient care in hematology and cardiovascular settings.
Bivalirudin is a direct thrombin inhibitor used during coronary angioplasty or intervention to prevent blood clot formation. Aspirin is a common antiplatelet medication that is given to prevent platelet aggregation and reduce the risk of clot formation. When used together, bivalirudin and aspirin provide a dual mechanism of action to prevent clot formation and maintain blood flow during the procedure.
Option B) Fondaparinux; Heparin is incorrect because fondaparinux is a factor Xa inhibitor, while heparin is a different type of anticoagulant. These medications are not typically used together during coronary angioplasty.
Option C) Enoxaparin; Coumarins is incorrect because enoxaparin is a low molecular weight heparin and coumarins are vitamin K antagonists. These medications are not commonly used together during coronary interventions.
Option D) Vitamin K inhibitors; Xa is incorrect because vitamin K inhibitors and Xa inhibitors do not directly address the immediate need for anticoagulation during coronary angioplasty. These medications are used for different indications and are not typically given concurrently during this procedure.
In an educational context, it is important for healthcare professionals to understand the rationale behind the selection of medications for specific procedures like coronary angioplasty. Knowing which medications work synergistically to prevent complications and understanding the mechanisms of action of different anticoagulants and antiplatelet agents is crucial for providing safe and effective patient care in hematology and cardiovascular settings.